PerkinElmer
check quantity

Apo-CIII (human) LANCE Ultra TR-FRET Detection Kit, 500 Assay Points

The LANCE® Ultra Human Apo-CIII Detection Kit is designed for detection and quantitation of ApoC3 in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

Please enter valid quantity

Please login to add favorites

NULL OR EMPTY CART

Part Number Unit Size List Price Your Price Quantity
TRF1396C 500 Assay Points 750.00 USD
TRF1396M 10,000 Assay Points 10000.00 USD
Buy Now

You successfully added item(s) to your cart

Overview

The LANCE® Ultra Human Apo-CIII Detection Kit is designed for detection and quantitation of ApoC3 in buffered solution and cell culture media using a homogeneous TR-FRET (no-wash steps, no separation steps) assay.

  • No-wash steps, no separation steps
  • TR-FRET technology
  • Sensitive detection
  • High reproducibility
  • Faster time-to-results
  • Easy automation
  • 96-well, 384-well, and 1536-well formats

LANCE® and LANCE® (Lanthanide chelate excite) Ultra are our TR-FRET (time-resolved fluorescence resonance energy transfer), homogeneous (no wash) technologies. One antibody of interest is labeled with a donor fluorophore (a LANCE Europium chelate) and the second molecule is labeled with an acceptor fluorophore (ULight™ dye). Upon excitation at 320 or 340 nm, energy can be transferred from the donor Europium chelate to the acceptor fluorophore if sufficiently close for FRET (~10 nm). This results in the emission of light at 665 nm.

Apolipoprotein CIII (ApoCIII), a relatively small protein (79 amino acids), is a component of very low density lipoproteins. Apo-CIII delays the catabolism of triglyceride rich particles by inhibiting the activities of lipoprotein lipase, hepatic lipase, and blocks the uptake of triglyceride-rich particles by the cells. Therefore, ApoCIII has been associated with coronary heart disease and diabetes. An increase in ApoCIII levels induces the development of hypertriglyceridemia and associated with non-alcoholic fatty liver disease.

Disclaimer:  For research use only. Not for use in diagnostic procedures.

Specifications

Assay Target ApoC3
Assay Target Class Protein
Automation Compatible Yes
Detection Method Time-Resolved Fluorescence (TRF), TR-FRET
Experimental Type In vitro
Product Brand Name LANCE Ultra
Shipping Condition Blue Ice
Target Species Human
Therapeutic Area Metabolic
Unit Size 500 Assay Points

Resources, Events & More

Resource Type File Name File Format
Brochure LANCE product listing PDF  77 KB
Application Note Quantifying Bcl-2 Expression Levels in Human Cells with LANCE Ultra TR-FRET PDF  3 MB
Manual LANCE Ultra Human Apo-CIII Detection kit TRF1396 PDF  512 KB
Flyer LANCE Ultra Biomarker Detection Kits PDF  585 KB